Skip to content
ROIV·Nasdaq·US

Roivant

Roivant is a biopharmaceutical company that builds and finances subsidiary operating companies to develop, license, and commercialize drug candidates and life-science technologies. It generates revenue from product sales, licensing and collaboration agreements, milestone and royalty economics, and occasional asset or subsidiary monetization.

Thematic Position

ROIV

Relationship Groups

Suppliers3
Partners1
Licensing3

Relationship details are part of the Pro plan.

Ended Relationships

3 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

import restrictionprice control
FDA final rule permits importation of price-controlled Canadian drugs
SEC 10-KMay 20, 2026

The full regulatory passage is part of the Pro plan.

14 more · Regulatory and geopolitical insights are part of the Pro plan.